No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 9, 2016, Pages 1356-1360

  Norton, Brianna L ^a   Southern, William N ^a   Steinman, Meredith ^a   Smith, Bryce D ^b   Deluca, Joseph ^a   Rosner, Zachary ^a   Litwin, Alain H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiviral Agent; Cascade of Care; Patient Management; Population; Therapy

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BIRTH; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT CARE; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SCREENING TEST; TREATMENT RESPONSE; VIRUS LOAD; AGED; DISEASE MANAGEMENT; HEALTH SERVICES RESEARCH; MASS SCREENING; MIDDLE AGED; PROCEDURES;

ADULT; AGED; DISEASE MANAGEMENT; FEMALE; HEALTH SERVICES RESEARCH; HEPATITIS C; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84997112319     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.04.017     Document Type: Article

References (16)

1. 1 Armstrong, G.L., Wasley, A., Simard, E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006), 705–714.
2. 2 Denniston, M.M., Jiles, R.B., Drobeniuc, J., et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 160 (2014), 293–300.
3. 3 Chak, E., Talal, A.H., Sherman, K.E., et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 31 (2011), 1090–1101.
4. 4 Ly, K.N., Xing, J., Klevens, R.M., et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 156 (2012), 271–278.
5. 5 Rein, D.B., Wittenborn, J.S., Weinbaum, C.M., et al. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis 43 (2011), 66–72.
6. 6 Davis, G.L., Alter, M.J., El-Serag, H., et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138 (2010), 513–521 521 e511–516.
7. 7 Recommendations for testing, managing, and treating hepatitis C. In: AASLD; IDSA; 2014. Available at: http://www.hcvguidelines.org.
8. 8 Holmberg, S.D., Spradling, P.R., Moorman, A.C., et al. Hepatitis C in the United States. N Engl J Med 368 (2013), 1859–1861.
9. 9 Yehia, B.R., Schranz, A.J., Umscheid, C.A., et al. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One, 9, 2014, e101554.
10. 10 Chou, R., Cottrell, E.B., Wasson, N., et al. Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 158 (2013), 101–108.
11. 11 Smith, B.D., Morgan, R.L., Beckett, G.A., et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 61 (2012), 1–32.
12. 12 Litwin, A.H., Smith, B.D., Drainoni, M.L., et al. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. Dig Liver Dis 44 (2012), 497–503.
13. 13 Mehta, S.H., Genberg, B.L., Astemborski, J., et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health 33 (2008), 126–133.
14. 14 Treloar, C., Hull, P., Dore, G.J., et al. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev 31 (2012), 918–924.
15. 15 Southern, W.N., Drainoni, M.L., Smith, B.D., et al. Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. J Viral Hepat 18 (2011), 474–481.
16. 16 Drainoni, M.L., Litwin, A.H., Smith, B.D., et al. Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting. Am J Public Health 102 (2012), e115–121.